Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Russell, Heidi; Street, Andrew; Ho, Vivian (2016)
Publisher: American Society of Clinical Oncology
Journal: Journal of Oncology Practice
Languages: English
Types: Article
Subjects: 36, Health Policy, Original Contributions, 164

Classified by OpenAIRE into

mesheuropmc: health care economics and organizations, animal structures
Purpose: State-based Medicaid programs have begun using All Patient Refined–Diagnosis-Related Groups (APR-DRGs) to determine hospital reimbursement rates. Medicaid provides coverage for 45% of childhood cancer admissions. This study aimed to examine how well APR-DRGs reflect admission costs for childhood cancer chemotherapy to inform clinicians, hospitals, and policymakers in the wake of policy changes. Methods: We identified 25,613 chemotherapy admissions in the 2009 Kids’ Inpatient Database. To determine how well APR-DRGs explain costs, we applied a hierarchic linear regression model of hospital costs, allowing for a variety of patient, hospital, and geographic confounders. Results: APR-DRGs proved to be the most important predictors of admission costs (P < .001), with costs increasing by DRG severity code. Diagnosis, age, and hospital characteristics also predicted costs above and beyond those explained by APR-DRGs. Compared with admissions for patients with acute lymphoblastic leukemia, costs of admissions for patients with acute myelomonocytic leukemia were 82% higher; non-Hodgkin lymphoma, 20% higher; Hodgkin lymphoma, 25% lower; and CNS tumors, 27% lower. Admissions for children who were 10 years of age or older cost 26% to 35% more than admissions for infants. Admissions to children’s hospitals cost 46% more than admissions to other hospital types. Conclusion: APR-DRGs developed for adults are applicable to childhood cancer chemotherapy but should be refined to account for cancer diagnosis and patient age. Possible policy and clinical management changes merit further study to address factors not captured by APR-DRGs.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Averill RF, Goldfield N, Hughes JS, et al: All Patient Refined Diagnosis Related Groups (APR-DRGs): Version 20.0-Methodology Overview. https://www.hcup-us. ahrq.gov/db/nation/nis/APR-DRGsV20MethodologyOverviewandBibliography.pdf
    • 2. Florida Senate: 2011 Florida statutes 409.905. http://www.flsenate.gov/Laws/ Statutes/2011/409.905
    • 3. Texas Medicaid & Healthcare Partnership: Hospital Services Handbook: Inpatient Reimbursement. http://www.tmhp.com/HTMLmanuals/TMPPM/2011/ 2011TMPPM-29-081.html
    • 4. California Department of Health Care Services: DRG reimbursement implementation. http://www.dhcs.ca.gov/provgovpart/Pages/DRG-Important-Info.aspx
    • 5. Ohio Department of Medicaid: Hospital payment policy. http://www.medicaid.ohio.gov/ PROVIDERS/ProviderTypes/HospitalProviderInformation/HospitalPaymentPolicy.aspx
    • 6. New York Department of Health: Official compilation of the rules and regulations of the state of New York: Title 10 volume A-2-Section 86-1.23: Exempt units and hospitals. http://w3.health.state.ny.us/dbspace/NYCRR10.nsf/0/ 8525652c00680c3e8525652c006eb454?OpenDocument
    • 7. Illinois General Assembly: Public Act 097-0689. http://www.ilga.gov/legislation/ publicacts/97/PDF/097-0689.pdf
    • 8. Price A, Stranges E, Elixhauser A: Pediatric Cancer Hospitalizations, 2009: HCUP Statistical Brief #132. Rockville, MD, US Agency for Healthcare Research and Quality, 2012,
    • 9. Russell HV, Okcu MF, Kamdar K, et al: Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admission. BMC Med Inform Decis Mak 14:88, 2014
    • 10. Berry JG, Hall M, Hall DE, et al: Inpatient growth and resource use in 28 children's hospitals: A longitudinal, multi-institutional study. JAMA Pediatr 167: 170-177, 2013
    • 11. Healthcare Cost and Utilization Project: Introduction to the HCUP KIDS' inpatient database. https://www.hcup-us.ahrq.gov/db/nation/kid/kid_2009_introduction.jsp
    • 12. Healthcare Cost and Utilization Project: NIS description of data elements: APRDRG-All Patient Refined DRG. http://www.hcup-us.ahrq.gov/db/vars/aprdrg/ nisnote.jsp
    • 13. Healthcare Cost and Utilization Project: Cost-to-charge ratio files. https://www. hcup-us.ahrq.gov/db/state/costtocharge.jsp
    • 14. Tunes-da-Silva G, Klein JP: Cutpoint selection for discretizing a continuous covariate for generalized estimating equations. Comput Stat Data Anal 55:226-235, 2011
    • 15. US Census Bureau: Census regions and divisions of the United States. http:// www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf
    • 16. Street A, Kobel C, Renaud T, et al: How well do diagnosis-related groups explain variations in costs or length of stay among patients and across hospitals? Methods for analysing routine patient data. Health Econ 21:6-18, 2012
    • 17. Cutler DM: The incidence of adverse medical outcomes under prospective payment. Econometrica 63:29-50, 1995
    • 18. Grabowski DC, Afendulis CC, McGuire TG: Medicare prospective payment and the volume and intensity of skilled nursing facility services. J Health Econ 30: 675-684, 2011
    • 19. He D, Mellor JM: Hospital volume responses to Medicare's Outpatient Prospective Payment System: Evidence from Florida. J Health Econ 31:730-743, 2012
    • 20. Parnell AS, Shults J, Gaynor JW, et al: Accuracy of the all patient refined diagnosis related groups classification system in congenital heart surgery. Ann Thorac Surg 97: 641-650, 2014
    • 21. Deppe S, Truax CB, Opalek JM, et al: Speaking the same language: Underestimating financial impact when using diagnosis-related group versus ICD-9-based definitions for trauma inclusion criteria. J Trauma 66:1184-1188, 2009
    • 22. Busse R; EuroDRG group: Do diagnosis-related groups explain variations in hospital costs and length of stay? Analyses from the EuroDRG project for 10 episodes of care across 10 European countries. Health Econ 21:1-5, 2012
    • 23. Scheller-Kreinsen D, Quentin W, Geissler A, et al: Breast cancer surgery and diagnosis-related groups (DRGs): Patient classification and hospital reimbursement in 11 European countries. Breast 22:723-732, 2013
    • 24. Peltola M, Quentin W: Diagnosis-related groups for stroke in Europe: Patient classification and hospital reimbursement in 11 countries. Cerebrovasc Dis 35: 113-123, 2013
    • 25. Gaughan J, Kobel C, Linhart C, et al: Why do patients having coronary artery bypass grafts have different costs or length of stay? An analysis across 10 European countries. Health Econ 21:77-88, 2012
    • 26. Mills RE, Butler RR, McCullough EC, et al: Impact of the transition to ICD-10 on Medicare inpatient hospital payments. Medicare Medicaid Res Rev 1:2, 2011
    • 27. Russell H, Swint JM, Lal L, et al: Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: A report from the Children's Oncology Group. Pediatr Blood Cancer 61:970-976, 2014
    • 28. Scalo JF, Rascati KL: Trends and issues in oncology costs. Expert Rev Pharmacoecon Outcomes Res 14:35-44, 2014
    • 29. van Litsenburg RR, Uyl-de Groot CA, Raat H, et al: Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: The influence of new medication and diagnostic technology. Pediatr Blood Cancer 57: 1005-1010, 2011
    • 30. Werba BE, Hobbie W, Kazak AE, et al: Classifying the intensity of pediatric cancer treatment protocols: The intensity of treatment rating scale 2.0 (ITR-2). Pediatr Blood Cancer 48:673-677, 2007
    • 31. Gamis AS, Alonzo TA, Perentesis JP, et al: Children's Oncology Group's 2013 blueprint for research: Acute myeloid leukemia. Pediatr Blood Cancer 60:964-971, 2013
    • 32. Kavcic M, Fisher BT, Li Y, et al: Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States. Cancer 119:1916-1923, 2013
    • 33. Sung L, Aplenc R, Alonzo TA, et al: Effectiveness of supportive care measures to reduce infections in pediatric AML: A report from the Children's Oncology Group. Blood 121:3573-3577, 2013
    • 34. Hunger SP, Loh ML, Whitlock JA, et al: Children's Oncology Group's 2013 blueprint for research: Acute lymphoblastic leukemia. Pediatr Blood Cancer 60: 957-963, 2013
    • 35. Law SP, Kim JJ, Decker JA, et al: Hospital charges for pediatric heart transplant hospitalizations in the United States from 1997 to 2006. J Heart Lung Transplant 31: 485-491, 2012
    • 36. Raphael JL, Mei M, Mueller BU, et al: High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer 58: 584-590, 2012
    • 37. Dugar DR, Lander L, Mahalingam-Dhingra A, et al: Pediatric acute sinusitis: predictors of increased resource utilization. Laryngoscope 120:2313-2321, 2010
    • 38. Romley JA, Chen AY, Goldman DP, et al: Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease. Health Serv Res 49: 588-608, 2014
    • 39. Children's Hospital Association: Hospital directory. https://www.childrenshospitals. org/Directories/Hospital-Directory
    • 40. Dobson A, DaVanzo J, Doherty J, et al: A Study of Hospital Charge Setting Practices.
    • 41. Ho V, Petersen LA: Estimating cost savings from regionalizing cardiac procedures using hospital discharge data. Cost Eff Resour Alloc 5:7, 2007
    • 42. Sun Y, Friedman B: Tools for More Accurate Inpatient Cost Estimates With HCUP Databases, 2009: Report #2014-04. Rockville, MD, US Agency for Healthcare Research and Quality, 2011 ICD.9-CM 140.X, 150.X, 171.X to 175.X, 179.X to 189.X, 190.X, 193.X, 194.0 to 194.29, 194.5 to 194.9, 195.X, 209.0 to 209.3
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article